Why Cameco (CCJ) Took the Crown: What 14.7% Debt-to-Equity Tells You

11 Points in a 6-Round Comparison — And Why

Cameco (CCJ) won the four-stock nuclear face-off with 11 points. Centrus came in second at 9, with BWXT and CEG tied for third at 8 each. Across the six rounds, CCJ placed first or second in four of them.

If I had to pick the single most important metric here, it's debt-to-equity at 14.7%. In the same comparison, BWXT carried 167.1% and LEU 159%. The piece below unpacks what that gap actually means.

Why Debt-to-Equity Matters Most Here

Nuclear projects move in 7-10 year cycles. Across that span, interest expense has to stay out of the way for there to be meaningful profit at the end.

A company carrying 150%+ debt-to-equity through a rate-hike regime sees a large share of operating cash flow drained by interest payments. Meanwhile, 14.7% is effectively unlevered. Interest expense is barely a factor, which leaves more operating cash flow available to return to shareholders.

I think of this as 'a balance sheet built to wait.' Even if short-term momentum is weak, the structure can survive to the end of the cycle.

The Other Rounds CCJ Won

CCJ led CROIC at 13.8%. This measures how efficiently management deploys capital. Hitting double-digit CROIC in a capital-intensive business like nuclear is uncommon.

Levered FCF margin at 30.9% was a dominant win. Second-place BWXT was at 9.2%, so the gap is more than 3x. That means after interest and taxes, more than 30% of revenue still drops to cash.

Net profit margin at 16.9% finished a narrow second to LEU's 17.3% — effectively a tie at the top.

The Weaknesses Are Real Too

Champion doesn't mean flawless. CCJ's biggest weakness is growth momentum.

On revenue growth forecast, CCJ was the only name in the negative at -1.7%. Dead last. That number is a function of the uranium price cycle and timing of long-term contract renewals — not a structure that generates headlines in the short term.

Valuation also carries a champion premium. Profit-adjusted PE of 6.51 is more than double LEU's 2.87 or CEG's 2.96. You pay for stability.

So I'd say CCJ fits investors who:

• Care about long-cycle returns over short-term momentum
• Want exposure to uranium price recovery rather than hyperscaler PPA headlines
• Need volatility management in their portfolio

What the Uranium Cycle Means for CCJ

Nuclear's structural tailwind ultimately translates into uranium demand. New reactor builds, restarts of existing reactors, and SMR commercialization all increase uranium consumption.

CCJ sits at the top of the uranium mining and refining value chain. While hyperscalers buy reactors, BWXT-types build microreactors, and CEG sells the electricity, CCJ is the one supplying fuel to all of them.

That said, uranium price volatility flows directly through CCJ's P&L. When the cycle is favorable, you get 30.9% FCF margin. When it flips, margin compresses fast.

Wrap

CCJ, the six-round champion, is the champion of stability and cash flow — not of growth and momentum. The combination of 14.7% debt-to-equity and 30.9% FCF margin is the financial profile best suited to surviving a 7-year project cycle.

If you want faster growth and headline momentum instead, CEG's 28.8% revenue growth in the same comparison is the more attractive pick. The champion isn't the right answer for every investor. But which name in this group is built to survive to the end of the cycle — that this comparison made clear.